by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Vice President of Risk Management at Professional Risk Management Services in Arlington, Virginia. Funding: No funding was provided for the preparation
Dear Colleagues: Welcome to the September–October 2019 edition of Innovations in Clinical Neuroscience (ICNS). We start this issue with a study titled, “Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and
by Takashi Ohnishi, MD, PhD; Hisanori Kobayashi, PhD; Tsutomu Yajima, MS; Takeshi Koyama, MS; and Kenichi Noguchi, PhD Drs. Ohnishi, Kobayashi, and Noguchi are with the Medical Affairs Division, Mr.
by Nolan Carlile, DO; Jared S. Link, PsyD; Allison Cowan, MD; and Elizabeth G. Sarnoski, MD Drs. Carlile, Cowan, and Sarnoski are with Wright State University in Dayton, Ohio. Drs.
by David G. Daniel, MD; Noah G. Daniel; Donald T. Daniel; Laura Copeland Flynn, MS; and Michael H. Allen, MD Dr. Daniel is with Bioniche Global Development, LLC in McLean,
by Erika D. Driver-Dunckley, MD; Nan Zhang, MS; Holly A. Shill, MD; Shyamal H. Mehta, MD, PhD; Christine M. Belden, PsyD; Edward Y. Zamrini, MD; Kathryn Davis; Thomas G. Beach,